NCT07089199
- Conditions
- Anlotinib, NSCLC, Nab-paclitaxel, +1 more
- Locations
-
- Qilu Hospital of Shandong University Jinan, Shandong, China
Clinical trial condition
Nab-paclitaxel
Explore clinical trials studying Nab-paclitaxel. Study availability and eligibility vary by location and protocol.
6 public trials
6 recruiting studies
Nab-paclitaxel trial results
NCT07233252
- Conditions
- Kidney-sparing, Nab-paclitaxel, PD-1 Inhibitor, +2 more
- Locations
-
- The Second Hospital of Tianjin Medical University Tianjin, Outside U.S., China
NCT04159142
- Conditions
- Breast Diseases, Breast Neoplasms, Nab-paclitaxel, +6 more
- Locations
-
- The Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China
NCT04138719
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- The Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China
NCT07126119
- Conditions
- Nab-paclitaxel, Neoadjuvant Therapy, PD-1 Inhibitor, +1 more
- Locations
-
- The Second Hospital of Tianjin Medical University Tianjin, Outside U.S., China
Recruiting
Neoadjuvant Tislelizumab + Nab-Paclitaxel Followed by Distal Ureterectomy for Ureteral Cancer
NCT07125547
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney-sparing, +14 more
- Locations
-
- The Second Hospital of Tianjin Medical University Tianjin, Outside U.S., China